Investors Research Corp’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
PCA
MSV
BTCPP
VFA
CAM
EB
AIM
FFA
QPBE
Investors Research Corp's LLY Position: Q3 2026 in Review
Investors Research Corp opened a new position in Eli Lilly (LLY) in Q3 2026: 21 shares worth $24.3K. The stake represents ﹤0.01% of the portfolio and ranks #450 among its holdings. This is a return to the name: Investors Research Corp previously reported a position in LLY as recently as Q4 2023.
Investors Research Corp first reported a position in LLY in Q1 2019 and has held it in 19 quarters since. The position peaked at $651K in Q4 2022. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Investors Research Corp held 21 shares of Eli Lilly worth $24.3K as of Q3 2026.
- Eli Lilly was a new Investors Research Corp position in Q3 2026.
- Eli Lilly made up ﹤0.01% of Investors Research Corp's portfolio in Q3 2026, its #450 holding.
- Investors Research Corp first reported a position in Eli Lilly in Q1 2019 and has held it in 19 quarters since.
- Investors Research Corp's Eli Lilly position peaked at $651K in Q4 2022.
- 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.